Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
Jialing Yin, Chengcheng Li, Chunhong Ye, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 824-837
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Advances in developing ACE2 derivatives against SARS-CoV-2
Haoran Zhang, Panjing Lv, Jingrui Jiang, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 5, pp. e369-e378
Open Access | Times Cited: 39
Brain Imaging Changes in Patients Recovered From COVID-19: A Narrative Review
Yan Huang, Qiong Ling, Anne Manyande, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 38
Reversal of the unique Q493R mutation increases the affinity of Omicron S1-RBD for ACE2
Angelin M. Philip, Wesam S. Ahmed, Kabir H. Biswas
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 1966-1977
Open Access | Times Cited: 27
Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants
Zi-Sin Yang, Tzong-Shiun Li, Yu-Sung Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
New Era in Systemic Sclerosis Treatment: Recently Approved Therapeutics
Satoshi Ebata, Asako Yoshizaki‐Ogawa, Shinichi Sato, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4631-4631
Open Access | Times Cited: 29
Anti-Entry Activity of Natural Flavonoids against SARS-CoV-2 by Targeting Spike RBD
Jieru Meng, Jiazheng Liu, Lu Fu, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 160-160
Open Access | Times Cited: 17
Host Response of Syrian Hamster to SARS-CoV-2 Infection including Differences with Humans and between Sexes
Martina Castellan, Gianpiero Zamperin, Giulia Franzoni, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 428-428
Open Access | Times Cited: 16
Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial
Muhammad Raza Shah, Samreen Fatima, Sehrosh Naz Khan, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 27
A diagnostic model for sepsis-induced acute lung injury using a consensus machine learning approach and its therapeutic implications
Yongxin Zheng, Jinping Wang, Zhaoyi Ling, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Covalent drug – An emerging framework for targeted drug development
Ritesh Bhole, Govinda O. Joshi, Harshad S. Kapare, et al.
Results in Chemistry (2024) Vol. 8, pp. 101615-101615
Open Access | Times Cited: 4
Derivatives of MOPS: promising scaffolds for SARS coronaviruses Macro domain‐targeted inhibition
Oney Ortega Granda, Karine Alvarez, Benjamin Morin, et al.
FEBS Journal (2025)
Open Access
Zirconium-Based Metal–Organic Frameworks as Acriflavine Cargos in the Battle against Coronaviruses─A Theoretical and Experimental Approach
Przemysław J. Jodłowski, Klaudia Dymek, Grzegorz Kurowski, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 25, pp. 28615-28627
Open Access | Times Cited: 21
Toxicity assessment of SARS-CoV-2-derived peptides in combination with a mix of pollutants on zebrafish adults: A perspective study of behavioral, biometric, mutagenic, and biochemical toxicity
Ítalo Nascimento Freitas, Amanda Vieira Dourado, Amanda Pereira da Costa Araújo, et al.
The Science of The Total Environment (2022) Vol. 858, pp. 159838-159838
Open Access | Times Cited: 20
Research and development of Chinese anti-COVID-19 drugs
Xiwei Ji, Xiangrui Meng, Xiao Zhu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4271-4286
Open Access | Times Cited: 19
Brain disorders: Impact of mild SARS-CoV-2 may shrink several parts of the brain
Puranam Revanth Kumar, B. Shilpa, Rajesh Kumar Jha
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105150-105150
Open Access | Times Cited: 11
AI-integrated network for RNA complex structure and dynamic prediction
Haoquan Liu, Zhuo Chen, Jiaming Gao, et al.
Biophysics Reviews (2024) Vol. 5, Iss. 4
Closed Access | Times Cited: 4
Targeting the omicron variant of SARS-CoV-2 with phytochemicals from Saudi medicinal plants: molecular docking combined with molecular dynamics investigations
Lina Eltaib, Abdulrahim A. Alzain
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 19, pp. 9732-9744
Closed Access | Times Cited: 17
Structural interactions of phytoconstituent(s) from cinnamon, bay leaf, oregano, and parsley with SARS‐CoV ‐2 nucleocapsid protein: A comparative assessment for development of potential antiviral nutraceuticals
Ishrat Husain, Rumana Ahmad, Sahabjada Siddiqui, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 10
Open Access | Times Cited: 16
Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants
Ji Woong Kim, Kyun Heo, Hyun Jung Kim, et al.
Antiviral Research (2023) Vol. 212, pp. 105576-105576
Open Access | Times Cited: 9
Engineering a NanoBiT biosensor for detecting angiotensin-converting enzyme-2 (hACE2) interaction with SARS-CoV-2 spike protein and screening the inhibitors to block hACE2 and spike interaction
Cheng‐Han Lin, Xinrui Yang, M. C. Lin, et al.
Biosensors and Bioelectronics (2024) Vol. 263, pp. 116630-116630
Closed Access | Times Cited: 3
Structure-guided design of a trivalent nanobody cluster targeting SARS-CoV-2 spike protein
Xinyi Jiang, Qin Qin, Haixia Zhu, et al.
International Journal of Biological Macromolecules (2023) Vol. 256, pp. 128191-128191
Closed Access | Times Cited: 8
Overview of Breastfeeding Under COVID-19 Pandemic
Zehan Pang, Ruolan Hu, Lili Tian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
A Comprehensive Overview of Sensors Applications for the Diagnosis of SARS-CoV-2 and of Drugs Used in its Treatment
Ahmet Çetinkaya, S. Irem Kaya, Síbel A. Özkan
Critical Reviews in Analytical Chemistry (2023) Vol. 54, Iss. 7, pp. 2517-2537
Closed Access | Times Cited: 7
Current status and future challenges in extraction, purification and identification of Cepharanthine (a potential drug against COVID-19)
Yu Wang, Xinbiao Zhou, Shuang Wei, et al.
Separation and Purification Technology (2022) Vol. 309, pp. 123038-123038
Open Access | Times Cited: 10
Effect of tocilizumab on ischemia-reperfusion-induced oxido-inflammatory renal damage and dysfunction in rats
Kezban Tuna Ozkaloglu Erdem, Zehra Bedir, Ufuk Kuyrukluyıldız, et al.
EXPERIMENTAL ANIMALS (2022) Vol. 71, Iss. 4, pp. 491-499
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top